Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Raquel Cristina Skrsypcsak"'
Autor:
Thais Almeida, Werner Schroth, Jeanine Marie Nardin, Thomas Mürdter, Solane Picolotto, Reiner Hoppe, Jenifer Primon Kogin, Elisa Daniele Gaio, Angela Dasenbrock, Raquel Cristina Skrsypcsak, Lucia Noronha, Hiltrud Brauch, José Claudio Casali-da-Rocha
Publikováno v:
Cancer Research. 82:P1-07
Tamoxifen is widely used in adjuvant therapy for breast cancer patients, but up to one-third of patients recur within 15 years after surgery even with its regular use. Low plasma levels of (Z)-endoxifen, the most active tamoxifen metabolite, have bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09b5b4e9f8048355bbe013fbad6f7a41
https://doi.org/10.1158/1538-7445.sabcs21-p1-07-08
https://doi.org/10.1158/1538-7445.sabcs21-p1-07-08
Autor:
Thais Almeida, Werner Schroth, Jeanine Nardin, Thomas E. Mürdter, Stefan Winter, Solane Picolotto, Reiner Hoppe, Jenifer Kogin, Elisa Gaio, Angela Dasenbrock, Raquel Cristina Skrsypcsak, Lucia de Noronha, Matthias Schwab, Hiltrud Brauch, José Claudio Casali-da-Rocha
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 4; Pages: 511
Adherence to treatment and use of co-medication, but also molecular factors such as CYP2D6 genotype, affect tamoxifen metabolism, with consequences for early breast cancer prognosis. In a prospective study of 149 tamoxifen-treated early-stage breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55ea366e5462b0524ff56950e1ed905